Details for New Drug Application (NDA): 010831
✉ Email this page to a colleague
NDA 010831 describes CORTICOTROPIN, which is a drug marketed by Organics Lagrange and Watson Labs and is included in two NDAs. Additional details are available on the CORTICOTROPIN profile page.
The generic ingredient in CORTICOTROPIN is corticotropin. There are ten drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the corticotropin profile page.
The generic ingredient in CORTICOTROPIN is corticotropin. There are ten drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the corticotropin profile page.
Summary for 010831
| Tradename: | CORTICOTROPIN |
| Applicant: | Organics Lagrange |
| Ingredient: | corticotropin |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 40 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 80 UNITS/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
